Arcus Biosciences Other Long Term Liabilities (Quarterly) Analysis

Arcus Biosciences, Inc. (RCUS)

24.56 +1.82 (+8.00%) USD | NYSE | Jan 14, 16:00

24.30 -0.26 (-1.06%) After-Hours: 20:00

View Other Long Term Liabilities (Quarterly) for RCUS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Gilead Sciences, Inc.	Upgrade
Actinium Pharmaceuticals, Inc.	--
Madrigal Pharmaceuticals, Inc.	--
Karyopharm Therapeutics, Inc.	Upgrade
Janux Therapeutics, Inc.	--